Oncology
Cancer clinical trials
Studies of cancers and tumors of every type and site, from prevention to treatment. We’re tracking 20,116 recruiting studies in this area right now.
By phase
- Not applicable9,488
- Phase 24,391
- Phase 12,658
- Phase 1/Phase 21,647
- Phase 31,391
- Phase 2/Phase 3281
- Phase 4260
Top conditions
- Breast Cancer1,192
- Prostate Cancer644
- Cancer632
- Colorectal Cancer478
- Lung Cancer415
- Ovarian Cancer336
- Multiple Myeloma328
- Pancreatic Cancer287
- Gastric Cancer283
- Acute Myeloid Leukemia279
- Hepatocellular Carcinoma256
- Solid Tumor245
- Advanced Solid Tumor235
- Head and Neck Cancer225
- Cervical Cancer223
- Endometrial Cancer206
- Advanced Solid Tumors199
- Esophageal Cancer189
Leading sponsors
- M.D. Anderson Cancer Center453
- Fudan University303
- National Cancer Institute (NCI)292
- Memorial Sloan Kettering Cancer Center290
- Sun Yat-sen University273
- Mayo Clinic237
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences140
- City of Hope Medical Center140
- AstraZeneca134
- Second Affiliated Hospital, Zhejiang University, School of Medicine128
Where studies are running
- California1,404
- Texas636
- Arizona513
- Florida431
- Alabama424
- New York407
- Massachusetts340
- Maryland332
- New Jersey269
- Pennsylvania234
Recruiting studies20,116 total
- NCT06185062Recruiting
Pelvic cancer registry for online adapted radiotherapy
This study collects data from patients receiving a type of radiation therapy that is adjusted in real-time. It aims to learn more about how well this approach works for pelvic and chest tumors.
GöttingenAges 18 years+ - NCT06247501RecruitingPhase 2
CAR-T therapy for children with B-cell ALL needing transplant
This study tests a new type of immune-cell therapy (called CAR-T cells) for children and young adults with a specific blood cancer (B-cell ALL) who need a stem cell transplant. The treatment uses a patient's own T-cells that are modified to find and kill cancer cells with the CD19 marker.
SeoulAges Up to 25 years - NCT06247605RecruitingPhase 3
Study of AL8326 for advanced small cell lung cancer
This trial tests a new oral drug called AL8326 for people with advanced small cell lung cancer who have already tried at least two other treatments. The goal is to see if the drug can shrink tumors and help patients live longer.
Changchun, JilinAges 18 years+ - NCT06249308Recruiting
Liquid biopsy test for early ovarian cancer detection
This study is testing a blood test to see if it can catch ovarian cancer early. You may be eligible if you have been recently diagnosed with ovarian cancer and haven't started treatment yet.
Guangzhou, GuangdongAges 40–75 - NCT06249256RecruitingEarly Phase 1
Fast CAR T cells for advanced solid tumors
This trial tests a new type of CAR-T cell therapy called Fast CAR T cells for people with advanced solid tumors. It is designed for patients whose tumors have certain markers (mesothelin and PD-L1) and who have not responded to or cannot tolerate standard treatments.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT06248697RecruitingEarly Phase 1
CAR-T cells targeting MSLN with PD-1/CTLA-4 blockers for advanced solid tumors
This trial tests a new type of immune cell therapy (CAR-T cells) that target a protein called MSLN on cancer cells, and also release a special antibody to block two other proteins (PD-1 and CTLA-4) that cancers use to hide from the immune system. It is for people with advanced solid tumors like non-small-cell lung cancer or mesothelioma who have not responded to standard treatments.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT05199376Recruiting
Cryotherapy treatment for painful, hard-to-remove NF1 tumors
This trial tests whether freezing treatment done through the skin (cryotherapy) can reduce pain and discomfort from certain non-cancer NF1 tumors that can’t be safely removed. You may be able to join if you’re an adult with NF1, a painful or bothersome benign lesion, and can safely undergo procedures like MRI.
LyonAges 18 years+ - NCT06202404Recruiting
Predicting cancer spread with a new imaging tool
This trial tests if a special imaging analysis can predict where your cancer might spread. It's for people with advanced lung, colorectal, or breast cancer who are starting or continuing treatment.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07855640Recruiting
Immunotherapy plus chemo for advanced stomach cancer with fluid in belly
This trial tests a new combination for advanced stomach cancer that has spread and caused fluid buildup in the belly (malignant ascites). It combines an immunotherapy drug (anti-PD-1) with standard chemotherapy and a targeted chemotherapy given directly into the belly to see if it can shrink the cancer and help you feel better.
Hangzhou, ZhejiangAges 18–75 - NCT07855926Recruiting
Perioperative drug therapy for muscle-invasive bladder cancer
This study looks at different drug treatments given around the time of surgery for muscle-invasive bladder cancer. It aims to understand how well these treatments work and may help guide future care.
MunichAges 18 years+ - NCT05221398Recruiting
Immunotherapy after liver cancer surgery
This trial tests whether giving immunotherapy after surgery to remove liver cancer can help lower the risk of the cancer coming back. It may be an option for people who have certain risk factors for recurrence.
Nanning, GuangxiAges 18–75 - NCT07866846Recruiting
Ketogenic diet for blood sugar side effects of pasireotide in acromegaly
This study tests whether a low-carbohydrate ketogenic diet can help manage high blood sugar caused by the medication pasireotide, which is used to treat acromegaly. If you are being considered for or already taking pasireotide and your blood sugar is rising, this diet might help you avoid or reduce the need for diabetes medications.
Leiden, South HollandAges 18 years+ - NCT05652283RecruitingPhase 2
Combination treatment before surgery for advanced ovarian cancer
This trial tests two oral medications, pamiparib and surufatinib, given before surgery to shrink advanced ovarian cancer. The goal is to make surgery more successful and potentially improve outcomes for patients who cannot have surgery right away.
Hefei, AnhuiAges 18 years+ - NCT07860047RecruitingPhase 2
Peptide vaccine with antibody therapy for prostate cancer
This trial tests a combination of a personalized peptide vaccine and an antibody therapy for men with prostate cancer that has returned after initial treatment. The goal is to see if this approach can control the cancer without needing stronger hormone therapy.
Heidelberg, Baden-WurttembergAges 18–80 - NCT07871838Recruiting
Shorter radiation course for endometrial cancer
This trial tests a shorter course of pelvic radiation for people with endometrial cancer after surgery. It aims to see if it is safe, works well, and improves quality of life.
Montreal, QuebecAges 18 years+ - NCT07173387RecruitingPhase 2
Radiation plus chemo for locally advanced pancreatic cancer
This trial combines focused radiation with a chemotherapy drug combo to help shrink or control locally advanced pancreatic cancer. If it works, this treatment might make the tumor smaller and improve quality of life.
Jinan, ShandongAges 18–75 - NCT07865780Enrolling by invitationPhase 1/Phase 2
Laser light with or without oxygen gel for mouth sores from radiation
This study tests two ways to treat painful mouth sores caused by radiation therapy for head and neck cancer. Half of the participants will receive laser light therapy alone, and the other half will receive laser light plus an oxygen gel applied to the sores. The goal is to see if adding the oxygen gel helps the sores heal faster and reduces pain.
AsyutAges 18 years+ - NCT07860372Recruiting
Nutrition supplements before cancer surgery
This trial compares two types of nutritional supplements given to patients before cancer surgery. One is a special mix that boosts the immune system, and the other is rich in omega-3 fats (EPA and DHA). The goal is to see which one helps patients recover better after surgery.
Córdoba, CórdobaAges 18–85 - NCT07874321RecruitingPhase 2
Study of MRG003 for advanced thyroid cancer that has progressed on current therapy
This trial tests an investigational drug called MRG003 added to your current treatment for advanced thyroid cancer that has stopped responding. It may help people with specific types of thyroid cancer and certain tumor markers.
Guangzhou, GuangdongAges 18–80 - NCT06251388RecruitingPhase 2
Chemoradiation plus Cadonilimab for advanced cervical cancer
This trial tests whether adding an immunotherapy drug called Cadonilimab (AK104) to standard chemoradiation can help people with locally advanced cervical cancer that has not spread to distant organs. The goal is to improve treatment outcomes for those who cannot have surgery.
Chengdu, SichuanAges 18–75 - NCT06250595Recruiting
European rare blood disorder registry
This study is building a registry of people with rare blood diseases. By joining, you help doctors learn more about these conditions and improve future care.
Barcelona, CataloniaAges Up to 100 years - NCT06254521RecruitingPhase 2
Tislelizumab plus chemo before surgery for MSS rectal cancer
This trial tests a combination of an immunotherapy drug (tislelizumab) plus chemotherapy before surgery for people with a specific type of rectal cancer that has not spread to other organs. The goal is to see if this approach can shrink the tumor more effectively than standard treatment.
Nanning, GuangxiAges 18 years+ - NCT05988814RecruitingPhase 2
FOLFIRINOX3 for advanced pancreatic cancer
This trial tests a stronger version of FOLFIRINOX chemotherapy for people with pancreatic cancer that cannot be removed by surgery or has spread to other parts of the body. It aims to see if the new dosing schedule works better and is safe.
DijonAges 18 years+ - NCT06254690RecruitingPhase 2
Pyrotinib dosing study for HER2-positive advanced breast cancer
This trial tests different doses of pyrotinib, a targeted therapy, for women with HER2-positive advanced breast cancer that has not yet been treated for recurrence. It aims to find the best dosing regimen to control the cancer.
Nanjing, JiangsuAges 18–70
Common questions
- How many cancer clinical trials are recruiting?
- Clin2 is tracking 20,116 recruiting oncology studies from the U.S. registry right now, out of 29,780 we cover in this area in total.
- What does “Cancer” cover here?
- Studies of cancers and tumors of every type and site, from prevention to treatment. We group each study into cancer based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a cancer trial near me?
- Use the search to filter cancer studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.